Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Women with PCOS have more emotional and body image issues than healthy women.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Removing external lipids from hair reduces moisture and increases strength, while removing internal lipids decreases water permeability.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Acne is an important sign of androgen excess disorders in women.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Both genetic and lifestyle factors significantly affect female hair loss.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

High energy boosts root hair growth in plants, while low energy stops it.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Finasteride causes lasting fertility decrease in rats.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

A woman developed male traits from accidental contact with her husband's testosterone gel.